|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 160.60 EUR | -0.62% |
|
+4.96% | +35.04% |
| Aug. 04 | Marengo Therapeutics, Inc. and Ipsen S.A. Nominate First Drug Candidate Under Strategic Tristar Collaboration | CI |
| Aug. 03 | Jefferies Downgrades Ipsen to Underperform, Boosts PT | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| IPSEN | Other Pharmaceuticals | -0.62% | +4.96% | +35.04% | +52.03% | +77.77% | 15.32B |  |  |  |
- Stock Market
- Stocks
- IPN Stock
- Charts Ipsen
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
